Cardiovascular Disease

>

Latest News

Remission from Type 2 Diabetes via Lifestyle Intervention Reduces Risk for CVD, CKD / Image credit: ©PH-HY/AdobeStock
Remission from Type 2 Diabetes via Lifestyle Intervention Reduces Risk for CVD, CKD

March 27th 2024

Longer duration of remission was associated with a greater reduction in CKD and CVD risk, according to a post hoc analysis of the Look AHEAD study.

COVID-19 Vaccines Reduce Risk of Cardiac, Thromboembolic Outcomes: Daily Dose / image credit: ©New Africa/AdobeStock
COVID-19 Vaccines Reduce Risk of Cardiac, Thromboembolic Outcomes: Daily Dose

March 27th 2024

Bempedoic Acid Associated with Reduced CV Risk in Statin-Intolerant Individuals Regardless of Ethnicity / Image credit: ©molekuul.be/AdobeStock
Bempedoic Acid Associated with Reduced CV Risk in Statin-Intolerant Individuals Regardless of Ethnicity

March 26th 2024

FDA Expands Bempedoic Acid Label to Include Primary, Secondary CV Risk Reduction, With or Without Statins / image credit ©Waldenmarus/stock.adobe.com
FDA Expands Bempedoic Acid Label to Include Primary, Secondary CV Risk Reduction, With or Without Statins

March 24th 2024

COVID-19 Vaccines Reduce Risk of Cardiac, Thromboembolic Outcomes for up to 1 Year, According to New Data / Image credit: ©Tsuboya/AdobeStock
COVID-19 Vaccines Reduce Risk of Cardiac, Thromboembolic Outcomes for up to 1 Year, According to New Data

March 21st 2024

More News

© 2024 MJH Life Sciences

All rights reserved.